Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04736433 · ClinicalTrials.gov registry record
Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.
A clinical trial, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 6,066
- Enrollment target
NCT04736433: Completed study, sponsored by Brigham and Women's Hospital.
NCT04736433 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 6,066 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04736433 has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 6,066 participants
- Enrollment target
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Interventions
- DRUG ACE inhibitor
- DRUG Sacubitril/Valsartan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,066 participants |
| Start Date | 2020-09-22 |
| Est. Completion | 2021-02-18 |
What the finished NCT04736433 record still lists
NCT04736433 is an observational study that tracks outcomes without assigning an intervention. Its 6,066 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which ACE inhibitor is the first listed.
NCT04736433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04736433 about?
NCT04736433 is a clinical study titled "Replication of the PARADIGM-HF Heart Failure Trial in Healthcare Claims Data.". Investigators are building an empirical evidence base for real world data through large-scale replication of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such...
What is the current status of trial NCT04736433?
This trial is currently completed. The enrollment target is 6,066 participants. The study started on 2020-09-22. Estimated completion is 2021-02-18.
What interventions are being tested in trial NCT04736433?
The interventions under investigation include: ACE inhibitor (DRUG), Sacubitril/Valsartan (DRUG).
Who is sponsoring clinical trial NCT04736433?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07166861 · 6,080 participants · NA
Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI